Thus, to further characterize the features of circulating Treg in MS individuals, we evaluated the expression of PD-1 in CD4+CD25brightCD45RA− cells by flow cytometry, in PBMCs obtained from MS and HD. This evidence concerns the gene CD4 and myeloid sarcoma.